What serum IgG level cutoff indicates when to start IVIG (intravenous immunoglobulin) in a child, and how frequently should it be administered?

IVIG Initiation and Dosing for Primary Immunodeficiency in Children

IVIG replacement therapy should be initiated in children with significantly impaired antibody production (such as X-linked agammaglobulinemia, CVID, or combined immunodeficiencies), administered at 300-600 mg/kg every 3-4 weeks, with the goal of maintaining trough IgG levels above 500 mg/dL. 1, 2

Indications for Starting IVIG

The decision to initiate IVIG is not based on a single IgG cutoff value alone, but rather on the diagnosis of a primary immunodeficiency disorder with significantly impaired antibody production. 1

Key considerations for initiation:

• Diagnoses warranting IVIG include: X-linked agammaglobulinemia (XLA), common variable immunodeficiency (CVID), Wiskott-Aldrich syndrome, severe combined immunodeficiencies, and other disorders with significantly impaired antibody production 2

• Clinical context matters: The presence of recurrent bacterial infections in the setting of low IgG levels strengthens the indication for therapy 1

• Early initiation is critical: Delays in starting immunoglobulin replacement can lead to permanent organ damage (bronchiectasis, bronchiolitis obliterans) or death from overwhelming infection 1

Dosing and Frequency

Standard Dosing Protocol

Administer 300-600 mg/kg body weight (6-12 mL/kg) intravenously every 3-4 weeks. 2

• The specific dose within this range should be adjusted based on clinical response and trough IgG levels 2

• Target trough IgG level: >500 mg/dL to prevent severe bacterial infections and pulmonary complications 3, 4

• Some evidence suggests maintaining trough levels at 700 mg/dL may provide additional protection against infections 3

Special Circumstances

For measles exposure risk: If the patient receives <400 mg/kg every 3-4 weeks and is at risk of measles exposure (outbreak or travel to endemic areas), increase the dose to at least 400 mg/kg 2

Post-measles exposure: Administer the dose as soon as possible after known exposure 2

Monitoring Requirements

Monitor trough IgG levels, complete blood counts, and serum chemistry at minimum every 6-12 months. 1

• More frequent monitoring (every 3-6 months) is advisable in younger, growing children 1

• Trough levels should be measured immediately before the next scheduled infusion 1

• Adjust dosing for excessive infections, growth/weight changes, or conditions causing increased IgG loss (enteric loss, increased metabolism) 1

Important Clinical Pitfalls

IgA Deficiency is NOT a Contraindication

Low or absent IgA (<7 mg/dL) does not preclude IVIG therapy when IgG replacement is indicated. 1

• Anaphylaxis to IVIG in IgA-deficient patients is extremely rare 1

• If anaphylaxis occurs with IVIG, subcutaneous immunoglobulin may be tolerated 1

Infusion Rate Considerations

Start slowly and titrate up based on tolerance: 2

• First 30 minutes: 0.5 mg/kg/min (30 mg/kg/hr)
• Second 30 minutes: 1.0 mg/kg/min (60 mg/kg/hr) if tolerated
• Third 30 minutes: 2.0 mg/kg/min (120 mg/kg/hr) if tolerated
• Maximum rate: 3.33 mg/kg/min (200 mg/kg/hr)

For patients at risk of renal dysfunction or thromboembolism, use the minimum infusion rate practicable, not exceeding 0.07 mL/kg/min (3.3 mg/kg/min or 200 mg/kg/hr). 2

Avoid Permanent Central Venous Access

Do not place permanent central venous catheters solely for IVIG administration due to unacceptable infection risk. 1 Consider subcutaneous immunoglobulin as an alternative for difficult venous access 1

Adjunctive Measures

Even with adequate IVIG replacement, consider:

• Aggressive antimicrobial therapy with prolonged courses for breakthrough infections 1

• Prophylactic antibiotics for patients with recurrent respiratory infections despite adequate IVIG 1